{"name":"Cardurion Pharmaceuticals, Inc.","slug":"cardurion-pharmaceuticals-inc","ticker":"","exchange":"","domain":"cardurion.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CRD-4730","genericName":"CRD-4730","slug":"crd-4730","indication":"Other","status":"phase_2"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"IMR-687","genericName":"IMR-687","slug":"imr-687","indication":"Treatment of sickle cell disease","status":"phase_2"}]}],"pipeline":[{"name":"CRD-4730","genericName":"CRD-4730","slug":"crd-4730","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"IMR-687","genericName":"IMR-687","slug":"imr-687","phase":"phase_2","mechanism":"Potassium channel opener","indications":["Treatment of sickle cell disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPWVd5VXNVcUJfbUNSVzM5Z1JEYkZYbnc4cWlEbUhlNml4MlJibk1DZGltLVhlYlYyRU4tZWc5YmQwOWk1Vk5Eb2FENGZTVnZXek1tOUJNSlQ5WGtfMjhHbUppOUw0cjVyU0VUSDVHMjhvVTZ4SDR4aDFURmtBUFY2RmpnM0N5eUdpS1JlYTRJY1NpbGpJX0dqM0ZNVkN0SzA?oc=5","date":"2025-08-06","type":"trial","source":"Yahoo Finance","summary":"Cardurion Pharmaceuticals Completes Enrollment in Phase 2 CYCLE Trials Evaluating CRD-750, a Novel PDE9 inhibitor, in Heart Failure - Yahoo Finance","headline":"Cardurion Pharmaceuticals Completes Enrollment in Phase 2 CYCLE Trials Evaluating CRD-750, a Novel PDE9 inhibitor, in He","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNTHU5dTFvZGVMZ2x1TkUtMnlnMjBIcnFqeGRNbXhJRF9OemlJUWEzaTNMbkRaMTFYN3lWYXlmNjNQN1BGV3FjdFNsZU4xLW54QmxJT0p1d0NodC1zdm82N3A2dzAzaF9OamFMUkNWSl9LVmFmTE5aY1l0bTBTTTIxYVBnTGFoZ2EyN1prWNIBkgFBVV95cUxOUS03QkhadF8tOFFJTHo0bE1RRkZYeEQzMFFNQWpiSWpYcnYwZmlSMlhPWXVVREt2SFdNLVVjNTItaHhKVm1hcUR3a3ZqaDNXTGlJVlBOd3ZvdGlKSVJWd2xFYWFDdW9kQjBvTXJVRnZqbTZDeEd0RmFoWUQyWW9DQlFLbklqYXZzZWJxTjUwUkR5QQ?oc=5","date":"2025-02-12","type":"deal","source":"Pulse 2.0","summary":"Bain Capital To Buy Mitsubishi Tanabe Pharma In $3.3 Billion Deal - Pulse 2.0","headline":"Bain Capital To Buy Mitsubishi Tanabe Pharma In $3.3 Billion Deal - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPeWxwQXhOa0pBRmItRlNUMmxCYXhRZGxMQkhEbUhaREpUQW5NdmdVLUR3OEZ1UzNIUWd2QjlwRG9kVU0wdFlGZXFvaE9ZU3VvX0xIaEdvRzk3clV6bi0yNU9oNktuZ1ZYeVlYaDVUd1k0a3BPNHhSOUlEVHRzY2dwNTRXekdzRkF1cTNQaVc3UGJFUHVWLVc1RTIyRmhYZmZla0luNFZmQWFJQldhcnZ6MEZ2V0FpZHhPVWppdGZSam1NelFBbkgwbl9YeXVwVmM?oc=5","date":"2025-01-08","type":"pipeline","source":"Business Wire","summary":"Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer - Business Wire","headline":"Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNcTNfdDdWcE1WWkpNSElUQjAzbEtGQUJtUU84d0VMSUhDbmF0RVltZGRlOGFFWXRURHZES0dqUG5nbHBpMTJSRW41WGdjaXl2a2NFRVB5SHpJX2NFekg1RjhIVWlneDF4R1pncnh2a1N6ZkNxVjYzMWpuTi1rOEFBXy1QT2llbHEwYkg0a1JiZk1hbFJWQXFKSGdvUmtnVm9jMVhCandUemRRVWZ3R05rWW5hdVRBYlNPcjJpdWI3RExEZG01Qmxqd09UVS04RWF2QUNQUFkxNzE?oc=5","date":"2024-09-27","type":"trial","source":"Business Wire","summary":"Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company - Business Wire","headline":"Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOREdzc0V6VWF6YWFiMkw2aFpFclBHUkFOMUNaSnlTamxxZWlZT3FRbFNkQnQ2UzUwS0YtcGV5bEV5c2ZzTUZtTm9DMTFwZTVEam5mVEJtZDZtT3BoX3JnOGxYWWc5YmZfbTBMLWFpVWZDUlA0RUhuVVBuN0pfS3FVYXZuQ0RVZWFhTUdxWWRxVkZpeVc3SUV6TzJacjAycEhSQkFQMFFMcnJNaU9CeVVmZ0ZFSF9JZXFZXzZGcVFB?oc=5","date":"2024-09-26","type":"trial","source":"Endpoints News","summary":"Endpoints 11 winner Cardurion Pharmaceuticals: A shot at one of heart disease’s 'undruggable' targets - Endpoints News","headline":"Endpoints 11 winner Cardurion Pharmaceuticals: A shot at one of heart disease’s 'undruggable' targets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPOHNPamJueVpVZzJ4Q2l4RGk5UktZMk9JRmtXRVRaTTFJNlBjeUVqSDlVMTluQVNBOTFrX09JWVJPMkJjN3BOdDlDY2dNMXlNUGN2MWRWTWJibmR1UEJsSldzRFNzeHlpREJlY1MtblZiOEV5OUVpcmQ4NmY3LWtkRklYX011dE1mQzRvUTZvYkNDVGl2SGpoN0hoU1o?oc=5","date":"2024-07-16","type":"pipeline","source":"BioPharma Dive","summary":"Cardurion raises another $260M to fuel heart drug pipeline - BioPharma Dive","headline":"Cardurion raises another $260M to fuel heart drug pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQX3I1ZjFON1hNcHF1enBWR3pPNHd2SlhyOGwzMVF3WEZtNExjTGh6WW12ZzNCLU80cldqejJxV25BRjFsNHJIbXRBcWFVTmYzWnJOcF9MVHZrdHpsaF9zdDdPSWJXZWxxcnFDOS1MblhONldnc0c1cFExWnZOR1k5Tzc4Y3BVUVRsaXhFUE9GWHRWN1J1SHozS0R3VWNEUQ?oc=5","date":"2024-07-16","type":"pipeline","source":"Fierce Biotech","summary":"Cardio-focused Cardurion closes hearty $260M series B to challenge statin-dominated status quo - Fierce Biotech","headline":"Cardio-focused Cardurion closes hearty $260M series B to challenge statin-dominated status quo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQMFZjcVBkRms5X2FrVU9fUUdieVM0M2ZuaEpSVVBDVm9wUV9FN1FMTEg1VEc3LTIzVVlFTE1xaWc3NV9OMFpVODZpNDVVc1R1bWJ0cFRhc20wZTE0cGV1dk9MQzRLdm5sY3dfaUJyRmc0YUl6LWJTYi0wRlVWTFA5dmVQUQ?oc=5","date":"2024-07-16","type":"pipeline","source":"The Business Journals","summary":"Two local biotechs land $410M in investments as VC picks up - The Business Journals","headline":"Two local biotechs land $410M in investments as VC picks up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9WS2xhYWVjLS1UcE9BaDB5SFFvc1hzZWJoVTBteElSc25Jb1FMa2kyNERDS2dOWTE1d29EdFVxTEFMSkdZVEM2OGJmZTVmUVBlb2IwNC1JZXNXWW0yT19Xc3h6aDdERThaX0VodTVteUw5d0NvS2hVd0Rzaw?oc=5","date":"2023-06-08","type":"pipeline","source":"Labiotech.eu","summary":"Six companies that have made their name in the cardiovascular space - Labiotech.eu","headline":"Six companies that have made their name in the cardiovascular space","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNSlo4Y3dveGVwVkRxMUZSakRnc1U0NjEwRzByc296NGlkU2x2WWxVYnpaTjBfM19nRmhQQjh2VU1lVjZhT280ZnE5LV8zdDd0S1RpVE80UUdkaG5TcW40eENmam1QZEdpdDNCeFdfQlllSUhMRjhRVUxqT0RRNVk2RjN6dGJHNTg?oc=5","date":"2022-09-08","type":"pipeline","source":"BioPharma Dive","summary":"After safety setbacks, job cuts, Imara sells its top drug to a startup - BioPharma Dive","headline":"After safety setbacks, job cuts, Imara sells its top drug to a startup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQVWZUVHpGUmNLc05qWFdPS1UzYmtheWdMbWdfQ3F6dlIzR2dfZVVLajZHQjlEQ1RMUi1XU2VMNEdZSnJxdW1pMW5MbC1iUUdhWGRoTk9OX1ZxOWtMeFhSMzR5ZVdaVS04b1Z5N1l2bVlIdHJlbmRvbmFIWnE2VVNPZmZXSXJaZ01CT1NfZmZaWjN4TXdPNXZOWk9VUERYUElEc3pLNnFmZw?oc=5","date":"2021-10-27","type":"pipeline","source":"Bain Capital","summary":"Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital - Bain Capital","headline":"Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPSGE2OXJKZ2ZVNWl3eWVpZGpwM2ZNSTZDWXc2cUxGUlFIREE2R1lRck5ENGFqUUR1anlRSnJwTHpIb0U2a1ZFdHozUUJiRmNrOU5rcGVDRzRHN2NiTS1wQzhMZVF0VkhZN2RPX0FJT2V6Q29zRS1VTUo2T3FDVjhXZTE3NU5aVTFaU2hUVTJnb1pLT25hMlAwcmUtUWN6SlhDQVVYZWVrNzQwcjg1ekdFcG1QLXl3UEdzb1hBYUo1VFpreEhzeUdv?oc=5","date":"2017-08-03","type":"deal","source":"Pharmaceutical Technology","summary":"Japan’s Takeda and Cardurion partner to develop new heart disease treatments - Pharmaceutical Technology","headline":"Japan’s Takeda and Cardurion partner to develop new heart disease treatments","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}